<DOC>
	<DOCNO>NCT00091039</DOCNO>
	<brief_summary>RATIONALE : Vaccines make gene-modified virus may make body build immune response kill tumor cell . Drugs use chemotherapy , paclitaxel carboplatin , work different way stop tumor cell divide stop grow die . Radiation therapy use high energy x-rays damage tumor cell . Combining vaccine therapy chemotherapy radiation therapy may kill tumor cell . PURPOSE : This clinical trial study well give vaccine therapy together paclitaxel , carboplatin , radiation therapy work treat patient stage III non-small cell lung cancer remove surgery .</brief_summary>
	<brief_title>Vaccine Therapy , Chemotherapy , Radiation Therapy Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed With Surgery</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine safety feasibility standard paclitaxel , carboplatin , radiotherapy combination vaccinia-CEA-TRICOM vaccine , fowlpox-CEA-TRICOM vaccine , recombinant fowlpox GM-CSF vaccine patient unresectable stage III non-small cell lung cancer . Secondary - Determine clinical response patient treat regimen . - Determine time disease progression overall median survival patient treat regimen . - Determine immunologic response patient treat regimen . OUTLINE : This pilot study . - Vaccine : Patients receive vaccinia-CEA-TRICOM vaccine subcutaneously ( SC ) day 0 fowlpox-CEA-TRICOM ( rF-CEA-TRICOM ) vaccine SC day 14 , 29 , 43 , 57 , 70 , 91 , 112 . Patients also receive recombinant fowlpox GM-CSF ( rF-GM-CSF ) vaccine SC vaccination . Patients stable respond disease day 112 continue receive rF-CEA-TRICOM rF-GM-CSF SC every 3 week absence disease progression unacceptable toxicity . - Radiotherapy : Patients undergo radiotherapy day 21-25 , 28-32 , 35-39 , 42-46 , 49-53 , 56-60 , 63-67 . - Chemotherapy : Concurrently radiotherapy , patient receive paclitaxel IV 1 hour carboplatin IV 30 minute day 21 , 28 , 35 , 42 , 49 , 56 , 63 . Patients also receive paclitaxel carboplatin day 91 112 ( completion radiotherapy ) . Patients follow annually 15 year . PROJECTED ACCRUAL : A total 10 patient accrue study within 4-6 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm nonsmall cell lung cancer Stage III ( locally advance ) disease Unresectable disease Carcinoembryonic antigen ( CEA ) positive ( stain ≥ 20 % cell ) tumor immunohistochemistry HLAA2positive No distant metastasis PATIENT CHARACTERISTICS : Age 18 Performance status ECOG 01 Life expectancy At least 6 month Hematopoietic Granulocyte count ≥ 1,500/mm^3 Platelet count ≥ 100,000/mm^3 Absolute lymphocyte count ≥ 600/mm^3 Hemoglobin ≥ 10 g/dL Hepatic Bilirubin &lt; 1.5 mg/dL AST ≤ 2 time upper limit normal Hepatitis B C negative Renal Creatinine normal OR Creatinine clearance &gt; 60 mL/min Cardiovascular No unstable newly diagnose angina pectoris No myocardial infarction within past 6 month No New York Heart Association class IIIV congestive heart failure Immunologic HIV negative No alter immune function No active history eczema No atopic dermatitis No autoimmune disease , include follow : Autoimmune neutropenia , thrombocytopenia , hemolytic anemia Systemic lupus erythematosus Sjögren 's syndrome Scleroderma Myasthenia gravis Goodpasture 's syndrome Addison 's disease Hashimoto 's thyroiditis Active Graves ' disease Multiple sclerosis No known history allergy serious reaction prior vaccination vaccina No know allergy egg No active history extensive psoriasis , severe acneiform rash , impetigo , varicella zoster , burn , traumatic pruritic skin condition Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 4 month study participation No history seizures encephalitis Able avoid close household contact follow individual least 3 week vaccinia vaccination : Children 3 year age Pregnant nursing woman Individuals history active eczema eczematoid skin disorder Individuals acute , chronic , exfoliative skin condition ( e.g. , atopic dermatitis , impetigo , burn , varicella zoster , severe acne , open rash wound ) Immunodeficient immunosuppressed individual , include HIVpositive person , disease therapy No active malignancy within past 2 year No concurrent serious illness PRIOR CONCURRENT THERAPY : Biologic therapy At least 3 year since prior immunotherapy relate vaccinia fowlpox vaccine At least 3 year since prior antigenspecific peptides No concurrent immunotherapy Chemotherapy No prior paclitaxel carboplatin lung cancer At least 3 year since prior chemotherapy No concurrent chemotherapy Endocrine therapy No concurrent steroid , except follow : Topical steroid Inhaled steroid mild moderate asthma Dexamethasone premedication paclitaxel OR shortterm dos ( 4872 hour duration ) control refractory nausea respond antiemetic Systemic corticosteroid ≥ grade 3 radiation pneumonitis No steroid eyedrops least 3 week vaccinia vaccination No concurrent hormonal therapy No concurrent systemic glucocorticoid Radiotherapy No prior radiotherapy lung field No prior thoracic radiotherapy lung cancer No concurrent radiotherapy Surgery Surgical scar must heal No prior splenectomy No concurrent major surgical procedure Other Recovered prior therapy No concurrent anticancer agent therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2005</verification_date>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
</DOC>